RxDoctor Payments Data

Stuart Hershman, MD

Orthopaedic Surgery of the Spine · Ft Lauderdale, FLNPI 1326202151

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $82,386 of the $118,853 with a category attached, or 69.3%. 12 manufacturers reported payments, led by Globus Medical at 48.2% of the total.

$118,853in general payments, 2019–2025

Across 172 payments — averaging $691.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$57K
  • Medical Device Business Services, Inc.$22K
  • Bioventus LLC$12K
  • Osteocentric Technologies, Inc.$12K
  • Biocomposites Inc$10K
  • Southern Spine, LLC$1K
  • plus $4K from 6 others
$10,021in research payments, 2019–2025

Across 5 payments — averaging $2004.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$10K
$99,979in ownership & investment interests, 2019–2025

Across 4 payments — averaging $24,995 each. An ownership or investment interest held by the physician or an immediate family member.

  • Osteocentric Technologies, Inc.$100K

What the payments were for

  • Consulting fees$82,38669%
  • Speaking & faculty fees$8,2507%
  • Travel & lodging$24,15520%
  • Food & beverage$4,0613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$118,853 in reported general payments places this provider in the 70th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida

Medicare billing

Part B allowed, 2024
$624,904
Medicare patients
229
Services billed
1,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide16$51,266
Gabapentin48$412

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Ft Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →